Industry News

PB Master Program Debuts: Xtep's New Global Support Platform for Marathon Runners

BERGEN, Norway, April 30, 2026 /PRNewswire/ -- Xtep, a leading global performance running brand, officially unveiled PB Master – a new flagship initiative under the X‑RUN Program – with a high‑energy debut at the 2026 Bergen City Marathon. The launch immediately struck a chord with local runners,...

2026-04-30 14:46 12863

WIEA Weibo International Entertainment Awards Makes Debut in Macau, Bringing Together Top Talent from China, Korea, and Thailand

MACAU, April 30, 2026 /PRNewswire/ -- The inaugural WIEA Weibo International Entertainment Awards was held from April 25 to 26, 2026, at Galaxy Arena in Macau, bringing together some of the biggest names in Asian entertainment from China, South Korea, and Thailand. Hosted by Weibo, one of China's...

2026-04-30 14:45 4427

Dreame Unveils Next-Generation Personal Care Lineup at DREAME NEXT 2026, Backed by 1,230% North American Growth

SAN FRANCISCO, April 30, 2026 /PRNewswire/ -- Dreame Technology, a global leader in high-end technology, today showcased its vision for smart personal care at the "Self Next" session of its DREAME NEXT Silicon Valley Launch Event, the company's global brand event unveiling new products across its...

2026-04-30 14:31 4963

Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases

SINGAPORE and TAIPEI, April 30, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. ("Formosa", 6838.TW) and the Singapore Eye Research Institute ("SERI") are pleased to announce a strategic research collaboration to develop next-generation ophthalmic formulations. This partnership will leverage ...

2026-04-30 14:30 5470

OMODA & JAECOO VPD Passes Tough Global Real-World Tests, Outperforms Seasoned Drivers to Enable True Parking Freedom

KUALA LUMPUR, Malaysia & WUHU, China, April 30, 2026 /PRNewswire/ -- Held alongside the Chery International Business Summit, OMODA & JAECOO has completed the first large-scale global public real-world field test of its flagship VPD (Valet Parking Driver) intelligent valet parking technology. The ...

2026-04-30 14:27 5413

Homestyler Hosts AIDA Global AI Design Awards Ceremony at Milan's ADI Design Museum

MILAN, April 30, 2026 /PRNewswire/ --The Homestyler AIDA Global AI Design Awards Ceremony was held at the ADI Design Museum in Milan, bringing together leading figures from international design, academia and industry to explore the future of AI‑empowered design. During the ceremony, members of th...

2026-04-30 14:26 3671

OceanBase Announces Further International Expansion with New Global Support Center in Malaysia

Deepens Global Localization Strategy to Provide Robust and Reliable Database Products for Fintech and Key Industries KUALA LUMPUR, Malaysia, April 30, 2026 /PRNewswire/ -- OceanBase today announced at its INFINITY 2026 conference in Kuala Lumpur the acceleration of globalization strategy. As a c...

2026-04-30 14:23 5145

Leading the AI Wave: E&R Brings Next-Gen Laser and Plasma Tech to SEMICON SEA 2026

KAOHSIUNG, April 30, 2026 /PRNewswire/ -- E&R Engineering (8027.TW) will showcase advanced laser and plasma solutions at SEMICON Southeast Asia 2026 next week. Targeting critical demands inAI, CPO, and next-generation manufacturing, E&R is partnering with Horng Terng Automation (HTA) and Group Up...

2026-04-30 14:21 3561

THE INDUSTRY CONVERGES AT ASIA PACIFIC RAIL 2026

BANGKOK, April 30, 2026 /PRNewswire/ -- Asia Pacific Rail 2026 (organised by Terrapinn) returns to the Bangkok International Trade and Exhibition Centre (BITEC) on 6-7 May, at a defining moment for the region's rail sector. Asia is in the midst of its most ambitious rail buildout. New high-speed ...

2026-04-30 13:39 3764

New Classification System of Malocclusions Published in the Journal of Aligner Orthodontics (JAO) by Prof. Gang Shen's Team

SHANGHAI, April 30, 2026 /PRNewswire/ -- A seminal research paper titled "A New Classification System for Malocclusions with Facial Convexity"has been officially published in the 2026 Volume 1 issue of the Journal of Aligner Orthodontics (JAO). This article, authored by Professor Gang Shen and hi...

2026-04-30 13:33 4562

Air Products to Expand Industrial Gas Supply for Samsung Electronics' Next-Generation Semiconductor Fab in South Korea

New investment underscores the company's long-term commitment to Korea and its leading role in the global semiconductor industry LEHIGH VALLEY, Pa., April 30, 2026 /PRNewswire/ -- On April 29, Air Products (NYSE:APD ), a ...

2026-04-30 13:21 4775

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

HONG KONG and HANGZHOU, China, April 30, 2026 /PRNewswire/ -- Hangzhou Diagens Biotech Co., Ltd. (HKEX: 2526, "Diagens"), a pioneer in medical imaging foundation models, today announced its first annual results since its listing. The report marks a pivotal milestone in the company's transition fr...

2026-04-30 13:18 6122

CHENGDU POLY TIME EDITION: Redefining Urban Life in Asia-Pacific Through Sports and Community

CHENGDU, China, April 30, 2026 /PRNewswire/ -- Located in Chengdu's Hi-Tech Zone, Poly Time Edition has emerged as a "social hub of relaxed aesthetics," attracting increasing attention from travelers and business professionals across the Asia-Pacific region. With over 100,000 square meters of com...

2026-04-30 13:02 3654

Landis+Gyr Announces Sale of Rhebo to Everfield

CHAM, Switzerland and LEIPZIG, Germany, April 30, 2026 /PRNewswire/ -- Landis+Gyr Group AG (SIX: LAND), a global energy technology leader driving intelligent innovation across the grid, today announced it has signed a definitive agreement to sell Rhebo GmbH to Everfield Germany GmbH, a buy-and-h...

2026-04-30 12:45 4719

Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025

AI-powered growth surges as Haier Biomedical scales from product coverage to premium brand leadership, building a global life science tools and intelligent productivity platform QINGDAO, China, April 30, 2026 /PRNewswire/ -- Haier Biomedical (688139.SH), a global leader in life sciences and medi...

2026-04-30 12:35 4627

GIGABYTE Wins Red Dot Design Award Across Its AI Product Lineup

TAIPEI, April 30, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, announces that its AI product lineup has been recognized by the Red Dot Design Award across graphics card, motherboard, and laptop categories, highlighting a cohesive approach to how local AI is built and experie...

2026-04-30 12:34 5160

2026 ESMO GC | Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations

SHANGHAI, April 30, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, today announced that two latest clinical study results of its novel Nectin‑4 targeting ADC (R&D code: 9MW2821) in cervical cancer will be ...

2026-04-30 12:26 5042

Elite Robots Launches RoboBarista to Revolutionize Self-Service Coffee Experiences in Commercial and Public Spaces

SHANGHAI, April 30, 2026 /PRNewswire/ -- Elite Robots , a global leader in collaborative robotics, today announcedRoboBarista, a fully autonomous coffee station designed for high-traffic commercial spaces. Combining precision cobot technology with professional brewi...

2026-04-30 12:13 4623

Driving the Global Food Revolution: Japan's Cutting-Edge Food Processing Technology Takes Center Stage

FOOMA JAPAN 2026 to Showcase Next-Generation Solutions Shaping the Future of Food Processing and Global Quality Standards TOKYO, April 30, 2026 /PRNewswire/ -- The Japan Food Machinery Manufacturers' Association (FOOMA) will host FOOMA JAPAN 2026, one of the world's largest comprehensive food pr...

2026-04-30 12:00 4525

D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types

Elisrasib monotherapy demonstrates notable efficacy in three major tumor types at its recommended phase 2 dose (RP2D, 600 mg QD). Phase 2 clinical outcomes include: * 2L+ KRAS G12Ci–naïve NSCLC: ORR of 58.8%, mPFS of 12.2 months * 2L+ colorectal cancer (CRC): ORR of 46.9%, mPFS of 9.5 months ...

2026-04-30 11:20 5287